Close 
News
Mar 2023 Three new members – RareStone Group, CTS, and Path Pharma World Orphan Drug Alliance Expands to China, Israel, and Greece, Cyprus, and Malta
The addition of three new members – RareStone, CTS, and Path Pharma – brings the total number of countries covered by WODA to 76.
Read more
Jan 2023 The multi-territorial agreement covers 41 countries World Orphan Drug Alliance Announces Agreement with Theratechnologies for the Distribution of EGRIFTA SV®
A long-term, multi-territorial distribution agreement with Theratechnologies Inc. ("Theratechnologies") for EGRIFTA SV® covers 41 countries.
Read more
Nov 2022 WODA Alliance to Expand Access and Pricing Support World Orphan Drug Alliance – partnering with Decisive Consulting to broaden access capability
WODA Alliance partners with Decisive Consulting to enhance access & pricing support for rare diseases & specialized therapeutics globally.
Read more
Jun 2022 WODA covers 68 countries on 4 continents World Orphan Drug Alliance – combining forces to reach patients with rare diseases across the globe
EffRx, Medis, Orpharm, OrphanDC & Vector Pharma form World Orphan Drug Alliance to support rare disease & specialized therapeutics globally.
Read more